CARAMBA HOLDING GMBH

caramba-holding-gmbh-logo

Caramba Holding GmbH manufactures and sells chemical products for cleaning, care, and maintenance applications.

#SimilarOrganizations #Financial #Website #More

CARAMBA HOLDING GMBH

Industry:
Health Care Manufacturing

Founded:
1903-01-01

Address:
Kรผnzelsau, Baden-Wurttemberg, Germany

Country:
Germany

Website Url:
http://www.caramba.eu

Total Employee:
1001+

Status:
Active

Contact:
(492)037-7860

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics LetsEncrypt Google Tag Manager WordPress Google Universal Analytics Apache Wordpress Plugins


Similar Organizations

not_available_image

Ciba Holding

Ciba Holding is manufactures and markets specialty chemicals that provide color, performance, and care for plastics.

Acquisitions List

Date Company Article Price
2011-12-30 Barnes Distribution Europe Barnes Distribution Europe acquired by Caramba Holding GmbH N/A

Official Site Inspections

http://www.caramba.eu Semrush global rank: 3.29 M Semrush visits lastest month: 4.95 K

  • Host name: www612.your-server.de
  • IP address: 162.55.254.209
  • Location: Germany
  • Latitude: 51.2993
  • Longitude: 9.491
  • Timezone: Europe/Berlin

Loading ...

More informations about "Caramba Holding GmbH"

Our company - Our mission - Caramba

Caramba โ€“ The brand of the century for the future Caramba is a German success story and has been your reliable partner with innovative strength and chemical know-how for 115 years. Since the filing of the first patent in 1903, our long โ€ฆSee details»

CARAMBA

The pioneering CARAMBA project has come to an end . On 30 th June 2023, the EU-funded project CARAMBA has come to an end, marking five years of challenges and successes in the โ€ฆSee details»

The Team - CARAMBA

Role in CARAMBA. The Universitätsklinikum Würzburg was the coordinating institution in CARAMBA and responsible for the successful conduct of the phase I/IIa clinical trial with โ€ฆSee details»

News - CARAMBA

On 30th June 2023, the EU-funded project CARAMBA is coming to an end, marking five years of challenges and successes in the mission to revolutionise multiple myeloma treatment and โ€ฆSee details»

Brand of the century - Caramba

As early as 2004, Caramba was awarded the coveted โ€œBrand of the Centuryโ€ seal of quality for the first time. Together with companies such as adidas, BMW, tesa or Tempo, Caramba thus โ€ฆSee details»

Milestones in the history of Caramba

Caramba graphite oil becomes the bestseller in Germany, the country of the economic miracle. 1965 Caramba is the first German company to develop a complete car care range. Due to its โ€ฆSee details»

CARAMBA: New Hope for Multiple Myeloma Patients - Presseportal

Jun 30, 2023 CARAMBA: the European pioneer for virus-free CAR-T cell immunotherapy against multiple myeloma On 30th June 2023, the EU-funded project CARAMBA is coming to โ€ฆSee details»

CARAMBA: a first-in-human clinical trial with SLAMF7 CAR-T cells ...

The CARAMBA clinical trial (Phase-I/IIA; EudraCT: 2019-001264-30) investigates the feasibility, safety, and anti-myeloma efficacy of autologous SLAMF7 CAR-T cells. CARAMBA is the first โ€ฆSee details»

CARAMBA: the European pioneer for virus-free CAR-T cell โ€ฆ

The EU-funded CARAMBA project has started in 2018 and is supported with a funding of 6.1 Mio โ‚ฌ. Within CARAMBA, ten partners of six EU countries are closely collaborating, among those โ€ฆSee details»

SLAMF7-CAR T cells prepared by Sleeping Beauty gene-transfer โ€ฆ

Since project start in 2018, the CARAMBA consortium has made rapid progress in implementing the project and clinical trial. The manufacturing authorization for SLAMF7 CAR T was obtained โ€ฆSee details»

Quality products for cleaning, maintenance and care | Caramba

New range of products for the technical trade. Caramba has expanded its range for the technical trade. Get to know the innovative high-performance chemicals for industrial and parts โ€ฆSee details»

CAR-T cell therapy advances treatment for multiple myeloma

The EU-funded CARAMBA project is using the revolutionary CAR-T cell technology to tackle multiple myeloma, developing a useful and affordable treatment for it and other rare diseases. โ€ฆSee details»

The pioneering CARAMBA project is coming to an end

On 30 th June 2023, the EU-funded project CARAMBA is coming to an end, marking five years of challenges and successes in the mission to revolutionise multiple myeloma treatment and โ€ฆSee details»

CARAMBA - Myeloma Patients Europe

The Horizon 2020 CARAMBA project started in January 2018. The project consortium is researching an innovative immunotherapy for the treatment of multiple myeloma, known as โ€ฆSee details»

CARAMBA: New Hope for Multiple Myeloma Patients - ARTTIC โ€ฆ

On 30th June 2023, the EU-funded project CARAMBA is coming to an end, marking five years of challenges and successes in the mission to revolutionise multiple myeloma treatment and โ€ฆSee details»

CARAMBA: a first-in-human clinical trial with SLAMF7 CAR-T cells ...

Apr 13, 2021 The CARAMBA clinical trial (Phase-I/IIA; EudraCT: 2019-001264-30) investigates the feasibility, safety, and anti-myeloma efficacy of autologous SLAMF7 CAR-T cells.See details»

Contact - Caramba

Contact Caramba โ€“ Call us on +49 (0)800 22 72 622See details»

Press Release | CARAMBA

In CARAMBA, the safety and efficacy of SLAMF7-specific CAR T cells will be evaluated in a Phase I/II clinical trial in patients. The European Commission selected the project from more โ€ฆSee details»

Caramba Company Profile 2024: Valuation, Investors, Acquisition

Www.caramba.eu. Ownership Status. Acquired/Merged. Financing Status. Corporate Backed or Acquired. Corporate Office. Wanheimer Strasse 334-336; 47055 Duisburg; Germany ...See details»

SLAMF7-CAR T cell treatment of Multiple Myeloma patients

CARAMBA was the first clinical trial to target the myeloma-specific protein SLAMF7. The project had a mission to better understand the role of CAR-T therapy in myeloma and to explore โ€ฆSee details»

linkstock.net © 2022. All rights reserved